Donna Johnston
Family Medicine · Melbourne, FLNPI 1447253463
Payments from drug & device makers
Across 99 payments — averaging $46.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz North America, Inc.$2K
- Biohaven Pharmaceuticals, Inc.$1K
- AbbVie$467
- Takeda Pharmaceuticals U.S.A., Inc.$188
- Titan Pharmaceuticals, Inc.$125
- Comsort, Inc$100
- plus $400 from 13 others
What the payments were for
- Consulting fees$1,30028%
- Speaking & faculty fees$1253%
- Travel & lodging$220%
- Food & beverage$3,15469%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz North America, Inc. | 24 | $1,950 |
| Biohaven Pharmaceuticals, Inc. | 7 | $1,371 |
| AbbVie(2 entities) | 33 | $467 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $188 |
| Titan Pharmaceuticals, Inc. | 1 | $125 |
| Comsort, Inc | 1 | $100 |
| Amarin Pharma, Inc. | 5 | $65 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $57 |
| Kowa Pharmaceuticals America, Inc. | 4 | $56 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
| Pfizer | 2 | $31 |
| Indivior Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Alkermes, Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Orexo US, Inc. | 1 | $16 |
| Exact Sciences | 1 | $16 |
| Almatica Pharma LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$1,489
- ASCLERA$1,339
- NURTEC ODT$1,300
- Probuphine$125
- ROTATEQ$100
- PNEUMOVAX 23$100
How this compares
$4,601 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 156 | $29,325 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 21 | $17,276 |
| OzempicSemaglutide | 12 | $15,882 |
| SuboxoneBuprenorphine Hcl/Naloxone Hcl | 12 | $6,213 |
| Atorvastatin Calcium | 88 | $1,794 |
| Levothyroxine Sodium | 96 | $1,627 |
| Losartan Potassium | 50 | $1,071 |
| Estradiol | 15 | $1,057 |
| Lisinopril | 62 | $772 |
| Omeprazole | 33 | $747 |
| Metformin Hcl ErMetformin Hcl | 31 | $673 |
| Simvastatin | 37 | $672 |
| Pantoprazole Sodium | 28 | $639 |
| Metoprolol Succinate | 23 | $622 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $611 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Orexo US, Inc.Zubsolv | $16 | $17,27621 claims |
| Indivior Inc.Suboxone | $24 | $6,21312 claims |
| Almatica Pharma LLCSertraline Hcl | $16 | $24415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.
Other family medicine in Melbourne
- Christopher GallowayMelbourne$15.6M
- Murray KimmelMelbourne$7.9M
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.